Company Overview of Neurop, Inc.
Neurop, Inc. is a biopharmaceutical company that develops treatments for central nervous system disorders. Its research targets various subunits of neuronal N-methyl-D-aspartate receptors and their therapeutic benefit to treat various central nervous system disorders, including major depression, neuropathic pain, ischemia (stroke), schizophrenia, Alzheimer’s, and Parkinson’s diseases. The company was founded in 2002 and is based in Atlanta, Georgia.
58 Edgewood Avenue, NE
Atlanta, GA 30303
Founded in 2002
Key Executives for Neurop, Inc.
Neurop, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Neurop, Inc., please visit www.neuropinc.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.